tiprankstipranks
Vaxil Bio Ltd (TSE:VXL)
TSXV:VXL
Canadian Market
Holding TSE:VXL?
Track your performance easily

Vaxil Bio (VXL) Income Statement

18 Followers

Vaxil Bio Income Statement

Last quarter (Q1 2024), Vaxil Bio's total revenue was C$―, a decrease of ― from the same quarter last year. In Q1, Vaxil Bio's net income was C$-58.00K. See Vaxil Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----C$ 0.00C$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 192.00KC$ 259.00KC$ 584.00KC$ 986.00KC$ 1.35MC$ 1.14M
Operating Income
C$ -192.00KC$ -259.00KC$ -584.00KC$ -986.00KC$ -1.35MC$ -1.14M
Net Non Operating Interest Income Expense
----C$ -11.00KC$ -11.00K
Other Income Expense
C$ -5.00KC$ -5.00K----
Pretax Income
C$ -187.00KC$ -254.00KC$ -584.00KC$ -986.00KC$ -1.36MC$ -1.15M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -187.00KC$ -254.00KC$ -584.00KC$ -986.00KC$ -1.36MC$ -1.15M
Basic EPS
--C$ -0.01C$ -0.01C$ -0.01C$ -0.01
Diluted EPS
--C$ -0.01C$ -0.01C$ -0.01C$ -0.01
Basic Average Shares
C$ 547.92MC$ 136.98MC$ 136.98MC$ 136.10MC$ 101.74MC$ 88.93M
Diluted Average Shares
C$ 547.92MC$ 136.98MC$ 136.98MC$ 136.10MC$ 101.74MC$ 88.93M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 33.00KC$ 24.00K
Total Expenses
C$ 134.00K-C$ 584.00K-C$ 1.35MC$ 1.14M
Interest Expense
----C$ 11.00KC$ 11.00K
Net Income From Continuing And Discontinued Operation
C$ -187.00KC$ -254.00KC$ -584.00KC$ -986.00KC$ -1.36MC$ -1.15M
Normalized Income
C$ -157.24KC$ -191.69KC$ -429.24KC$ -724.71KC$ -1.36MC$ -1.15M
EBIT
C$ -187.00KC$ -254.00KC$ -584.00KC$ -986.00KC$ -1.35MC$ -1.14M
EBITDA
C$ -187.00KC$ -254.00KC$ -582.00KC$ -961.00KC$ -1.29MC$ -1.04M
Currency in CAD

Vaxil Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis